Recent findings reveal a concerning dependency on foreign sources for key pharmaceutical ingredients critical to the United States' healthcare system, with a significant focus on China. This dependency places over a quarter of US-designated essential medicines at a 'very high risk,' sparking bipartisan efforts to address the nation's pharmaceutical supply chain vulnerabilities. https://bnnbreaking.com/breaking-news/health/over-25-of-us-essential-medicines-at-very-high-risk-due-to-dependency-on-china